http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DK-176068-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-285 |
filingDate | 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a17d819fe1eca234769ca8444d0eb7 |
publicationDate | 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DK-176068-B1 |
titleOfInvention | Recombinant canaripox virus and the use of the same |
abstract | A gene product (i) is expressed in a vertebrate by inoculating with a recombinant virus contg. DNA which encodes and expresses (I) without productive replication of virus in the host. Also new are (1) recombinant avipox virus contg. DNA from a non-avipox source in a non-essential region of its genome; (2) recombinant poxvirus contg. DNA from any source under control of an ontomopox promoter, and (3) recombinant vaccinia virus contg. DNA from any source under control of an avipox promoter. Specifically the virus is fowlpox or canary pox virus, and is inoculated by subcutaneous intradermal, intramuscular or oral methods, or into an egg. |
priorityDate | 1987-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 401.